期刊文献+

颈淋巴结阴性的甲状腺乳头状微灶癌中央组淋巴结转移的危险因素分析 被引量:2

Analysis clinical risk factors on central compartment lymph node metastasis in papillary thyroid mirrocarcinoma
原文传递
导出
摘要 目的了解甲状腺乳头状微灶癌(PTMC)气管旁淋巴结转移情况,探讨临床颈淋巴结阴性(c N0)PTMC患者发生Ⅵ区淋巴转移的危险因素。方法回顾性分析行患侧甲状腺根治性切除+颈Ⅵ区淋巴清扫术的120例c N0PTMC患者临床资料。根据术后病理检查分为Ⅵ区淋巴结转移组(40例)和未转移组(80例),并对可能的危险因素进行分析研究。结果 PTMC颈Ⅵ区淋巴结转移率为33.3%,单侧癌灶部位(P<0.05)、甲状腺包膜侵犯(P<0.05)、单侧多灶性PTMC(P<0.01)为Ⅵ区淋巴结转移的危险因素。结论 c N0PTMC有较高的颈部中央组淋巴结转移率,在切除甲状腺的同时清扫颈Ⅵ区的淋巴结是十分必要的,尤其有相关危险因素者。 Objective To analyze the risk factors of central compart-ment lymph node ( CCLN) metastasis in papillary thyroid micro carcino-ma ( PTMC ) without clinical cervical lymph node metastasis ( cN0 ) , according to the general situation of paratracheal lymph node metastasis in PTMC.Methods Clinical data of 120 PTMC ( cN0 ) patients who underwent radical thyroidectomy and CCLN dissection were retrospective-ly analyzed.Patients were divided into CCLN positive group ( 40 cases ) and CCLN negative group (80 cases) according to postoperative pathology results, and the risk factors were analyzed.Results The CCLN metasta-sis rate of PTMC was 33.3%.Position ( P〈0.05 ) , capsular invasion (P〈0.05), multifocal PTMC (P〈0.01) were the risk factors of CCLN metastasis.Conclusion The ( cN0 ) PTMC has a high rate of pathologi-cal CCLN metastasis.It is imperative to conduct the thyroidectomy with ipsilateral level Ⅵ lymph node dissection in PTMC patients , especially those with related risk factors.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2015年第2期96-98,共3页 The Chinese Journal of Clinical Pharmacology
关键词 甲状腺乳头状微灶癌 中央组淋巴结 颈淋巴结转移 LOGISTIC回归模型 papillary thyroid mirco carcinoma central compartment lymph node cervical lymph node metastasis Logistic regression mode
  • 相关文献

参考文献7

  • 1Rajeev P, Ahmed S, Ezzat TM, et al. The number of positive lymph nodes in the central compartment has prognostic impact ira papillary thyroid cancer[ J]. Langenbecal Arch Surg,20/3,398:377 - 382. 被引量:1
  • 2Leboulleux S, Girard E, Rose M, et al. Ultrasound criteria of malig- nancy for eervical lymph nodes in patients followed up for differen- tiated thyroid cancer[ J]. J Clin Endocrinol Metab,2007 ,92 :3590 - 3594. 被引量:1
  • 3Ito Y, Tomoda C, Uruno T, et al. Clinical significance of metastasis to the central compartment from papillary microcareinoma of the thyroid[ J ]. World J Surg,2006,30:91 - 99. 被引量:1
  • 4潘烨,郑起,樊友本,伍波,韩晓东.联合甲状腺全切除和中央区淋巴结清扫术治疗甲状腺乳头状癌安全性的meta分析[J].中华普通外科杂志,2010,25(8):631-634. 被引量:19
  • 5Wang TS, Dubner S, Sznyter LA, et al. Incidence of metastatic well - differentiated thyroid cancer in cervical lymph nodes[J]. Arch Otolaryn- gol Head Neck Surg,2004 ,130:110 - 113. 被引量:1
  • 6李树玲主编..新编头颈肿瘤学[M].北京:科学技术文献出版社,2002:1160.
  • 7巫泓生,古维立,梁柳森.细胞外基质在甲状腺癌转移机制的研究进展[J].中华内分泌外科杂志,2009,3(2):126-128. 被引量:7

二级参考文献13

  • 1Leboulleux S,Rubino C,Baudin E,et al.Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.J Clin Endocrinol metab,2005,90:5723-5729. 被引量:1
  • 2Machens A,Hinze R,Thomusch O,et al.Pattern of nodal metastasis for primary and reoperative thyroid cancer.World J Surg,2002,26:22-28. 被引量:1
  • 3Sadowski BM,Snyder SK,Lairmore TC.Routine bilateral central lymph node clearance for papillary thyroid cancer.Surgery,2009,146:696-705. 被引量:1
  • 4Henry JF,Gramatica L,Denizot A,et al.Morbidity of prophylactic lymph nodedissection in the central neck area in patients with papillary thyroid carcinoma.Langenbecks Arch Surg,1998,383:167-169. 被引量:1
  • 5Steinmüller T,Klupp J,Wenking S,et al.Complications associated with different surgical approaches to differentiated thyroid carcinoma.Langenbecks Arch Surg,1999,384:50-53. 被引量:1
  • 6Sywak M,Cornford L,Roach P,et al.Routine ipsilateral level Ⅵ lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer.Surgery,2006,140:1000-1007. 被引量:1
  • 7Roh JL,Park JY,Park CI.Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients:pattern of nodal metastasis,morbidity,recurrence,and postoperative levels of serum parathyroid hormone.Ann Surg,2007,245:604-610. 被引量:1
  • 8Palestini N,Borasi A,Cestino L,et al.Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience.Langenbecks Arch Surg,2008,393:693-698. 被引量:1
  • 9Grubbs EG,Rich TA,Li G,et al.Recent advances in thyroid cancer.Curr Probl Surg,2008,45:156-250. 被引量:1
  • 10Lee YS,Kim SW,Kim SW,et al.Extent of routine central lymph node dissection with small papillary thyroid carcinoma.World J Surg,2007,31:1954-1959. 被引量:1

共引文献23

同被引文献17

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部